Balance Performance and Quality of Life in Parkinson's Disease
The Relationship Between Performance-Based Balance Tests and Quality of Life in Individuals With Parkinson's Disease
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population.
Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
Studieoversikt
Status
Studietype
Registrering (Antatt)
Kontakter og plasseringer
Studiekontakt
- Navn: Büşra ÖZCAN, MSc
- Telefonnummer: +905533514349
- E-post: busra6873@gmail.com
Studer Kontakt Backup
- Navn: Borna FARHOOMAND, MSc
- Telefonnummer: +90544 903 36 38
- E-post: borna.farhoomand@gmail.com
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
The study population will consist of individuals diagnosed with idiopathic Parkinson's disease who are followed at the Neurology Department of Pamukkale University Hospital and age- and sex-matched healthy individuals recruited from the same geographical region in Denizli, Türkiye.
Beskrivelse
Inclusion Criteria:
- Willing to participate in the study and providing written informed consent
- Having a diagnosis of idiopathic Parkinson's disease
- Being 20 years of age or older
- Being classified as stage 1-3 according to the Modified Hoehn and Yahr Scale
- Being in the "on" medication state and undergoing assessment one hour after taking antiparkinsonian medication
Exclusion Criteria:
- Being a healthy individual matched for age and sex with a participant diagnosed with Parkinson's disease Willing to participate in the study and providing written informed consent Being 20 years of age or older
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Observasjonsmodeller: CASE_CROSSOVER
- Tidsperspektiver: CROSS_SECTIONAL
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Parkinson's Disease Group
Individuals diagnosed with Parkinson's disease who underwent assessments of balance, functional performance, fear of falling, disease severity, depressive symptoms, and quality of life. No intervention was administered as part of this observational study. |
|
Healthy Control Group
Age- and sex-matched healthy individuals without a diagnosis of Parkinson's disease who underwent balance and functional performance assessments. No intervention was administered as part of this observational study. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Health-Related Quality of Life Assessed by the PDQ-39
Tidsramme: During the single assessment session (approximately 25 minutes)
|
Health-related quality of life in individuals with Parkinson's disease will be assessed using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The PDQ-39 Summary Index ranges from 0 to 100, with higher scores indicating poorer health-related quality of life. |
During the single assessment session (approximately 25 minutes)
|
Samarbeidspartnere og etterforskere
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- E-60116787-020-677981
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .